AA

Abhishek Ashok Agrawal

Active Director Additional Director DIN 09126563
DIN 09126563 First appointment Mar 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Ashok Agrawal

Data last updated:

Abhishek Ashok Agrawal is an Additional Director at Kremedine Cancer Care Foundation (since 2021). The company operates in Healthcare.

DIN 09126563
Primary Designation Additional Director
Industry Healthcare
First Appointment 26 Mar 2021
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kremedine Cancer Care Foundation U85300MP2019NPL047883
Additional Director26 Mar 20212019Active

Board colleagues of Abhishek Ashok Agrawal

NameDINCompanyDesignation
Suyash Dubey07327643Kremedine Cancer Care FoundationDirector

Directorship timeline

Open interactive timeline →
Kremedine Cancer Care Foundation
Premium access

Shareholding and investment profile for Abhishek Ashok Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Ashok Agrawal

Abhishek Ashok Agrawal currently holds 1 directorship: Kremedine Cancer Care Foundation (Additional Director, since 26 Mar 2021).

Abhishek Ashok Agrawal was first appointed on 26 Mar 2021 as Additional Director at Kremedine Cancer Care Foundation.

The current boards of Abhishek Ashok Agrawal's companies include Suyash Dubey (Kremedine Cancer Care Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available